Drug discovery

#Covid-19 #Drug discovery #Research

Experts evaluate the effects of ACE2-mediated Covid-19 infection 

Bachem, a Swiss technology company active in the fields of chemistry, biochemistry and pharmaceuticals, as well as the development and production of peptides and oligonucleotides, analyses the findings from scientific research about the relationship between ACE2 and SARS-CoV-2.   Covid-19 has impacted almost everyone’s lives, whether through personal… Read More

#Covid-19 #Exclusive Content #News

#Drug development #Drug discovery #Pharma

Target product profiles and strategies for drug development

Hettie Stroebel, Founder and CEO of Launch Excellence looks at how target product profiles can be used by life sciences companies as a strategy for more effective product development.    The global effort to develop and distribute a SARS-CoV-2 vaccine in months is a triumph for the pharmaceutical industry. It is… Read More

#News #Opinion

#AAV #Drug discovery #Drug screening #NanoTemper Technologies

NanoTemper Technologies updates AAV/drug discovery portfolio  

NanoTemper Technologies has launched a number of updates to its portfolio of instruments to help researchers working in drug discovery and adeno-associated virus (AAV) therapies.  NanoTemper Technologies has launched its Spectral Shift technology to remove the roadblocks experienced by scientists dealing with really complex molecular interactions often… Read More

#News

#AI / data analytics / healthtech / informatics #Biotechnology #Drug discovery #Podcast

Scientific data management: What does your lab need? – podcast

This is the latest episode of the free DDW podcast, “Scientific data management: What does your lab need?”. It covers three narrated articles written for Volume 22, Issue 3 – Summer 2021 and Volume 22, Issue 4 – Fall 2021 of DDW.   The articles are… Read More

#News

#Automation / robotics #Drug discovery #Lab automation #Lab of the future

The rise of automation in drug discovery

Automation is not just for high-throughput screening anymore. New devices and greater flexibility are transforming what’s possible throughout drug discovery and development. This article was written by Thomas Albanetti, AstraZeneca; Ryan Bernhardt, Biosero; Andrew Smith, AstraZeneca and Kevin Stewart, AstraZeneca for a 28-page DDW eBook, sponsored by Bio-Rad. Download the… Read More

#Editor's Choice #Exclusive Content #News

#Assays #Drug discovery

Domainex supports growth with investment 

Domainex has purchased over £1 million worth of new Waters equipment to enhance its capabilities in analytical chemistry, bioanalytical sciences and in vitro absorbance, distribution, metabolism and excretion (ADME) assays. The company says the equipment will allow Domainex to increase its capacity and throughput, supporting its ongoing growth. … Read More

#News

#Biopharmaceuticals #Covid-19 #Drug discovery #Pharmaceutical #Therapeutics #Women in STEM

International Women’s Day: Female achievement in drug discovery

The theme for International Women’s Day 2022 is ‘Break the Bias’, in which society is encouraged to celebrate women’s achievements, in turn raising awareness against bias and inspiring positive action for equality. Though the initiative is interdisciplinary, the drug discovery, life science and pharmaceutical world boasts many achievements of this… Read More

#Editor's Choice #Exclusive Content #News #Opinion #Trending News

#Drug design #Drug discovery #Hotspot mapping

How hotspot mapping can accelerate early-phase drug design

In a recent paper in the Journal of Chemical Information and Modeling, authors from the Cambridge Crystallographic Data Centre (CCDC), Exscientia, and Oxford University show how an automated process leveraging “ensemble hotspot maps” can identify key structural differences that contribute to the selectivity of a compound for one protein over… Read More

#Editor's Choice #News

#Drug development #Drug discovery #Drug research #Pharmaceutical #Zebrafish

Appointment to help bridge the gap between isolated systems

The MDI Biological Laboratory (MDIBL) has appointed James Strickland as Director of MDI Bioscience, a new initiative focused on using non-mammalian models in early drug discovery and development.   Background  Strickland brings experience in pharmaceutical development to his new position, in which he will leverage… Read More

#News

#AI / data analytics / healthtech / informatics #Drug design #Drug discovery

Virtual drug design platform set to accelerate drug discovery 

The Cambridge Crystallographic Data Centre (CCDC) has entered a strategic partnership with Dassault Systèmes to advance bioscience innovation with a cloud-based virtual screening solution.  The collaboration  The collaboration integrates GOLD — CCDC’s protein-ligand docking software for drug discovery — with Dassault Systèmes’ BIOVIA therapeutics design… Read More

#News

#AI / data analytics / healthtech / informatics #Drug discovery #Lab automation #Podcast

Podcast: What do we know about lab automation? 

The latest episode of the free DDW podcast is titled“What do we know about lab automation?”. It covers two narrated articles written for Volume 22, Issue 3 – Summer 2021 of DDW, read by Megan Thomas.   The articles are “What has 2020 taught us… Read More

#News

#Approvals #Collaboration #Drug discovery #Public health #Research study

This week in drug discovery (14-18 February) 

News round-up by DDW’s Megan Thomas for 14-18 February, 2022  This week, DDW rounds up updates, approvals, research and trials which will enable scientists to make life-saving developments in the drug discovery industry.  1. Trial launched of HIV vaccine antigens delivered through mRNA technology… Read More

#News

#Biologics #Drug discovery

With biologic drug discovery mounting, CAS announces expansion 

CAS, a division of the American Chemical Society specialising in scientific information solutions, has launched an expansion of the CAS SciFinder Discovery Platform into life sciences. The enhanced platform includes over two million modified biosequences, 60 years of patent literature, and one of the largest collections of journal information… Read More

#News

#Biotechnology #DNA #Drug discovery #mRNA #Synthetic chemistry

From synthetic biology to synthesising DNA: helping advance research 

Evonetix is reimagining biology. Dr Vijay Narayan, Head of Physics, Dr Stuart Crosby, Head of Synthetic Chemistry, and Daniel Bygrave, Principal Software Engineer, offer insight into the technology being developed by the company and its relevance for researchers.  “I have always been intrigued by interdisciplinary environments,’… Read More

#Business & Investment #Editor's Choice #Exclusive Content #Intelligence #News #Trends & Analysis

#Collaboration #Drug discovery

This week in drug discovery (7-11 February) 

News round-up by DDW’s Megan Thomas for 7-11 February, 2022  This week has proved eventful in terms of progression in the drug discovery industry. DDW’s Megan Thomas flags five news stories which display this.  1. Additional dose of Covid-19 vaccine is safe, says US trial … Read More

#News #Trending News

#Biotechnology #Drug discovery #eBook #Lab automation

eBook: Your essential guide to drug discovery technology

This 28-page DDW eBook, sponsored by Bio-Rad, contains exclusive insight from industry experts on what’s new in lab automation and how this technology can accelerate your drug discovery process and is available to download now. With this guide, you can learn more about: The benefits of automation and how to… Read More

#News #Trending News